PrESS RELEASES
Edmonton Women’s Health Event Tackles Endometriosis Diagnosis
Edmonton, Alberta – Edmontonians are being invited to take part in the community led Women's Health Symposium taking place on April 25, 2026 at the Holiday Inn Conference Centre in South Edmonton, offering discussion and education on the recent elimination of the...
EndoDiagnosis Announces Links Medical Clinic as Western Canada’s First Permanent TIER-1 ENDOSURE Testing Program for the Rapid Diagnosis of Endometriosis
Led by Dr. Sam Azer, an Edmonton-based OBGYN, Links Medical Clinic becomes Western Canada’s first permanent ENDOSURE endometriosis test site. Located in Edmonton the clinic will now offer rapid, non-invasive endometriosis testing with results in 30 minutes.
EndoDiagnosis Announces CReATe Fertility as first Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis
London, Ontario: Dr. John McNaught, FRCSC, OB/GYN, MD and his teams at CReATe Fertility and London Women’s Health Care are focused on improving diagnosis of endometriosis at their London, Ontario fertility and women’s health clinic. They are the first medical center...
EndoDiagnosis, Inc Exhibits TIER-1 ENDOSURE Diagnostic Test for Endometriosis at AAGL 2025
EndoDiagnosis, Inc., is exhibiting at the American Association of Gynecologic Laparoscopists (AAGL) Global Congress taking place November 9-11, 2025, in Vancouver, British Columbia. Healthcare professionals, researchers, and industry leaders are invited to Booth #540...
PHAM and EndoDiagnosis Launch Ontario’s First-Ever Endo Road Show
OAKVILLE, ON, Aug. 7, 2025 /CNW/ - In collaboration with Dr. Kristy Prouse MD, FRCSC (OB/GYN), one of Canada's most respected leaders in hormonal health, and Endo Diagnosis, the team behind the revolutionary non-invasive Tier-One Diagnostic Test, PHAM is proud to...
ENDOSURE appoints EndoDiagnosis, Inc. Canadian Distributor to Revolutionize Endometriosis Detection in Canada with 30-Minute Non-Invasive ENDOSURE TEST
EndoDiagnosis is changing the landscape of women’s healthcare with its new role as the sole distributor in Canada for the ENDOSURE Tier 1 diagnostic test for endometriosis. This new diagnostic tool marks a significant shift in how endometriosis is detected and managed, cutting down the average diagnosis time from over eight years to just 30 minutes.
ENDOSURE Tier 1 Endometriosis Testing Now Available in North America for First Time, Through Primary Care Clinic Marda Loop Wellness
A North America first, primary care clinic Marda Loop Wellness is now offering ENDOSURE. This innovative, non-invasive diagnostic tool delivers results in 30 minutes with over 99% accuracy, addressing a critical gap in women’s healthcare where traditional diagnosis typically takes 8.6 years globally. The integration of ENDOSURE testing at Marda Loop Wellness aligns with the clinic’s unique approach to women’s healthcare. Patients can schedule ENDOSURE testing appointments beginning June 16, 2025.
Hope for Rapid, Non-Invasive Endometriosis Diagnosis
A breakthrough in women’s health: The ENDOSURE test delivers 99.87% accurate, non-invasive results for endometriosis in under an hour, potentially transforming care and cutting years off diagnosis time. Despite its Health Canada approval, access remains limited. Clinicians and advocates urge wider adoption to reduce delays, improve outcomes, and support early intervention for the 1 in 10 women affected. EndoDiagnosis aims to bring access to testing to patients and clinics across Canada.
Gastrointestinal Myoelectrical Activity (GIMA) Biomarker for Noninvasive Diagnosis of Endometriosis
Validation of New GIMA Biomarker Signature of Endometriosis
Don’t see a clinic near you?
We’ll let you know when new clinics open.